Remimazolam dosing: computer-controlled vs. manual
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two ways of giving the sedative remimazolam during brain bypass surgery. It looks at which method uses less medicine. If you are having this surgery, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You are scheduled for a type of brain surgery called cerebrovascular bypass.
- You are generally healthy or have a mild to moderate health condition (ASA class 1, 2, or 3).
- You are not allergic to benzodiazepine medicines.
- You do not have sleep apnea or severe breathing problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
This trial compares a newer anesthetic, remimazolam, to standard care to see if it helps prevent short-term memory or thinking problems after surgery on the aortic arch (a major artery in the chest). It also checks blood markers of brain inflammation. If you are having this type of surgery, this study might help protect your memory.
This trial tests a newer anesthetic drug, remimazolam, during heart surgery that uses a heart-lung machine. It aims to see if it is safe and works well for patients having this type of surgery.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
This trial compares two doses of a sedative called remimazolam (a sleep medication) to reduce confusion or agitation after waking up from nasal surgery. It aims to find which dose is safer and more effective for a smoother recovery.
Hear when a new Moyamoya Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.